Quarterly report pursuant to Section 13 or 15(d)

Other Balance Sheet Items (Tables)

v3.24.0.1
Other Balance Sheet Items (Tables)
3 Months Ended
Dec. 31, 2023
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
Table 9.1: Details of Cash and Cash Equivalents and Restricted Cash
December 31, 2023 September 30, 2023
(in thousands)
Cash and cash equivalents $ 104,186  $ 65,405 
Restricted cash 49,309  56,686 
Cash, cash equivalents, and restricted cash $ 153,495  $ 122,091 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Restrictions on Cash and Cash Equivalents
Table 9.1: Details of Cash and Cash Equivalents and Restricted Cash
December 31, 2023 September 30, 2023
(in thousands)
Cash and cash equivalents $ 104,186  $ 65,405 
Restricted cash 49,309  56,686 
Cash, cash equivalents, and restricted cash $ 153,495  $ 122,091 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Supplementary Cash Flow Information
Table 9.2: Supplemental Disclosures of Cash Flow Information
For the Three Months Ended
December 31, 2023 December 31, 2022
(in thousands)
Interest payments $ 20,522  $ 19,748 
Income tax (refunds)/payments, net $ (588) $ 4,982 
Details of Accounts Receivable
Table 9.3: Details of Accounts Receivable, Net
December 31, 2023 September 30, 2023
(in thousands)
Billed and billable receivables $ 708,145  $ 692,707 
Unbilled receivables 160,250  137,885 
Allowance for credit losses (7,986) (3,719)
Accounts receivable, net $ 860,409  $ 826,873